Stem cell treatments for skin regeneration: 2 things to know beforehand

The key to stem-cell procedures is not the cells themselves but the signaling substances they release (paracrine factors).

Adipose-derived stem cells (ADSCs), isolated from fat, are known to release signals that promote new blood vessels, skin-cell proliferation, collagen remodeling, and reduced inflammation.

A common misconception is that “stem cells turn directly into skin cells.” Reports suggest that this signaling role is more important than differentiation itself.

Adipose-derived stem cells can be obtained far more abundantly from the same amount of tissue than bone-marrow-derived cells, and collection under local anesthesia is another accessibility advantage.

Several different methods are grouped under the name “stem-cell procedures.”

Typical approaches use cells themselves, the medium remaining after cells are cultured, or purified exosomes—ultrafine vesicles secreted by cells.

Studies combining conditioned medium with lasers or microneedling have reported better wrinkle or pigmentation measures in the combination group than with the procedure alone.

However, these findings concern combination treatment; the same effects cannot readily be expected from use alone.

We consider three broad criteria together when choosing the method.

The first is the type of concern.

Prominent volume loss may lead to consideration of fat grafting, whereas skin texture or elasticity concerns shift the focus toward conditioned-medium or exosome-based approaches.

The second is whether combination treatment is feasible. Many studies reported better outcomes with lasers or microneedling, so combined treatment planning is considered.

The third is individual safety factors, such as medical history related to fish or blood products.

The reported onset and duration differ according to the outcome measured.

Some studies found significant improvements in skin thickness or elasticity relatively early, around 8–12 weeks. Others reported improvement in nasolabial folds or fine wrinkles lasting up to 12 months.

In contrast, some studies found pigmentation improvement at 3 months but a tendency for it not to persist at 6 months.

It is realistic to understand that not all outcomes improve at the same speed or last for the same period.

The most commonly reported reactions are injection-site pain, swelling, and bruising; most settle naturally within 4–5 days.

When combined with autologous fat grafting, rare procedural risks include calcification of fat lumps, cysts, and ischemia from intravascular injection. Cannulas and low-pressure, divided injections are therefore important.

Methods using cells themselves raise theoretical concerns about tumors and immune reactions. Korea therefore strictly regulates cultured and expanded stem cells at the pharmaceutical level.

Receiving a clear explanation of the regulatory scope and method from the clinic beforehand is the starting point for a safe choice.

These procedures may offer meaningful help if elasticity or thickness is gradually declining and you prefer regeneration over time to an immediate dramatic change.

The possibility of improving results through combination treatment can also be an advantage for these patients.

Conversely, expecting clear wrinkle or pigmentation changes within a short time may lead to lower satisfaction.

I believe this should be explained honestly, regardless of revenue.

We also explain plainly that some outcomes, such as pigmentation, vary widely between studies, and that long-term safety and standard doses are not yet established.

We select the approach based on the area of concern, expectations, and medical history, while explaining that even the same procedure may feel different depending on dermal condition and recovery capacity.